TechNewsReel
Live

AI Designs First Fully Functional Synthetic Viruses Not Found in Nature

Researchers use generative AI to create novel bacteriophages, marking a leap in synthetic biology and sparking biosecurity warnings.

TechNewsReel Newsroom · August 7, 2026

Researchers from Stanford University and the Broad Institute of MIT and Harvard have used generative AI to design the first fully functional viruses not found in nature. The breakthrough, published in the journal Science, demonstrates that AI can now architect complete, viable genomes from scratch rather than simply modifying existing organisms.

Using generative AI models known as Evo1 and Evo2, the team produced thousands of potential genomes based on bacteriophages—viruses that target bacteria. These models were trained on a vast array of genetic codes spanning humans, plants, bacteria, and viruses. After chemically synthesizing 302 of these AI-generated designs, the researchers found that 16 were viable. In laboratory tests, these synthetic viruses successfully infected and killed E. coli bacteria. Notably, a cocktail of these AI-designed viruses proved more effective at eliminating E. coli than naturally occurring viruses.

A Leap in Synthetic Biology

This achievement represents a significant escalation in the complexity of AI-driven design. While AI has previously been used to develop new antibiotics, designing a complete genome is far more complex because the resulting entity must be capable of replication and biological viability.

Brian Hie, an assistant professor at Stanford University, noted that this is the first time generative AI has been used to design a complete genome. Prof Patrick Cai, chair of synthetic genomics at the Manchester Institute of Biotechnology, added that the results suggest genome language models are beginning to master the fundamental design principles encoded by evolution.

Medical Potential and Biosecurity Risks

The ability to design custom viruses opens a new frontier for medical treatment, particularly in the fight against antibiotic-resistant "superbugs." By creating adaptive phage therapies, scientists could potentially engineer precise killers for bacteria that have evolved to resist traditional drugs. Because these specific synthetic viruses are bacteriophages, they only infect bacteria and pose no threat to human cells.

However, the capability to generate functional viral genomes from scratch introduces a critical biosecurity risk. Experts warn that the same technology used to create beneficial phages could potentially be misused to design dangerous human pathogens. Fatemeh Vafaee, a professor at the UNSW School of Biotech & Biomolecular Science, emphasized that the primary concern is not this specific virus, but the fact that AI is now capable of this feat at all.

The Path Forward

As the boundary between digital design and biological reality blurs, researchers are calling for urgent global governance and the implementation of screening guardrails to prevent misuse. The scientific community must now determine how to balance the immense therapeutic potential of synthetic genomics with the need for rigorous oversight to ensure these tools are not weaponized.

Sources

Get a notification when a big story breaks. A few a day at most — no spam.